Skip to main navigation
Skip to search
Skip to main content
University of Edinburgh Research Explorer Home
Help & FAQ
Home
Research output
Profiles
Research units
Projects
Datasets
Prizes
Activities
Press/Media
Equipment
Search by expertise, name or affiliation
New IDH1 mutant inhibitors for treatment of acute myeloid leukemia.
Jessy Cartier
Deanery of Clinical Sciences
Centre for Cardiovascular Science
Research output
:
Contribution to journal
›
Article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'New IDH1 mutant inhibitors for treatment of acute myeloid leukemia.'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Acute Myeloid Leukemia
100%
Allosteric Site
14%
Biological Activity
14%
Cells
28%
Cytosine
14%
Differentiation
14%
Enzyme
14%
In Vitro
14%
Isocitrate Dehydrogenase 1
100%
Leukemia
14%
Leukemia Cell
14%
Malignant Neoplasm
14%
Mutant
100%
Myeloid Differentiation
14%
Therapeutic Procedure
100%
Biochemistry, Genetics and Molecular Biology
Allosteric Site
14%
Biological Activity
14%
Conformation
14%
Cytosine
14%
Development
14%
DNA
14%
Isocitrate Dehydrogenase
100%
Lysozyme
14%
Mutant
100%
Mutation
28%
Myeloid
100%